T Hu1, L Yao2, K Reynolds3, T Niu4, S Li5, P Whelton5, J He5, L Bazzano5. 1. Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, SL-18, Suite 2000, New Orleans, LA 70112, USA. Electronic address: thu1@tulane.edu. 2. Division of Epidemiology and Community Health, University of Minnesota, 1300 S 2nd St, Suite 300, Minneapolis, MN 55454, USA. 3. Department of Research & Evaluation, Kaiser Permanente Southern California, 100 South Los Robles, 2nd Floor, Pasadena, CA 91101, USA. 4. Department of Biostatistics and Bioinformatics, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, SL-18, Suite 2001, New Orleans, LA 70112, USA. 5. Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, SL-18, Suite 2000, New Orleans, LA 70112, USA.
Abstract
BACKGROUND AND AIMS: The relationship between dietary macronutrient composition and appetite is controversial. We examined the effects of a year-long low-carbohydrate diet compared to a low-fat diet on appetite-related hormones and self-reported change in appetite. METHODS AND RESULTS: A total of 148 adults with a body mass index 30-45 kg/m(2), who were free of diabetes, cardiovascular disease and chronic kidney disease at baseline were randomly assigned to either a low-carbohydrate diet (carbohydrate [excluding dietary fiber]<40 g/day; N = 75) or a low-fat diet (<30% energy from fat, <7% from saturated fat; N = 73). Participants in both groups attended individual and group dietary counseling sessions where they were provided the same behavioral curriculum and advised to maintain baseline levels of physical activity. Appetite and appetite-related hormones were measured at 0, 3, 6 and 12 months of intervention. At 12 months, mean changes (95% CI) in peptide YY were -34.8 pg/mL (-41.0 to -28.6) and in the low-carbohydrate group and -44.2 pg/mL (-50.4 to -38.0) in the low-fat group (net change: 9.54 pg/mL [0.6 to 18.2]; p = 0.036). Approximately 99% of dietary effects on peptide YY are explained by differences in dietary macronutrient content. There was no difference in change in ghrelin or self-reported change in appetite between the groups. CONCLUSIONS: A low-fat diet reduced peptide YY more than a low-carbohydrate diet. These findings suggest that satiety may be better preserved on a low-carbohydrate diet, as compared to a low fat diet. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00609271.
RCT Entities:
BACKGROUND AND AIMS: The relationship between dietary macronutrient composition and appetite is controversial. We examined the effects of a year-long low-carbohydrate diet compared to a low-fat diet on appetite-related hormones and self-reported change in appetite. METHODS AND RESULTS: A total of 148 adults with a body mass index 30-45 kg/m(2), who were free of diabetes, cardiovascular disease and chronic kidney disease at baseline were randomly assigned to either a low-carbohydrate diet (carbohydrate [excluding dietary fiber]<40 g/day; N = 75) or a low-fat diet (<30% energy from fat, <7% from saturated fat; N = 73). Participants in both groups attended individual and group dietary counseling sessions where they were provided the same behavioral curriculum and advised to maintain baseline levels of physical activity. Appetite and appetite-related hormones were measured at 0, 3, 6 and 12 months of intervention. At 12 months, mean changes (95% CI) in peptide YY were -34.8 pg/mL (-41.0 to -28.6) and in the low-carbohydrate group and -44.2 pg/mL (-50.4 to -38.0) in the low-fat group (net change: 9.54 pg/mL [0.6 to 18.2]; p = 0.036). Approximately 99% of dietary effects on peptide YY are explained by differences in dietary macronutrient content. There was no difference in change in ghrelin or self-reported change in appetite between the groups. CONCLUSIONS: A low-fat diet reduced peptide YY more than a low-carbohydrate diet. These findings suggest that satiety may be better preserved on a low-carbohydrate diet, as compared to a low fat diet. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00609271.
Authors: R M Krauss; R H Eckel; B Howard; L J Appel; S R Daniels; R J Deckelbaum; J W Erdman; P Kris-Etherton; I J Goldberg; T A Kotchen; A H Lichtenstein; W E Mitch; R Mullis; K Robinson; J Wylie-Rosett; S St Jeor; J Suttie; D L Tribble; T L Bazzarre Journal: Circulation Date: 2000-10-31 Impact factor: 29.690
Authors: David E Cummings; David S Weigle; R Scott Frayo; Patricia A Breen; Marina K Ma; E Patchen Dellinger; Jonathan Q Purnell Journal: N Engl J Med Date: 2002-05-23 Impact factor: 91.245
Authors: T E Adrian; A P Savage; G R Sagor; J M Allen; A J Bacarese-Hamilton; K Tatemoto; J M Polak; S R Bloom Journal: Gastroenterology Date: 1985-09 Impact factor: 22.682
Authors: A D Howard; S D Feighner; D F Cully; J P Arena; P A Liberator; C I Rosenblum; M Hamelin; D L Hreniuk; O C Palyha; J Anderson; P S Paress; C Diaz; M Chou; K K Liu; K K McKee; S S Pong; L Y Chaung; A Elbrecht; M Dashkevicz; R Heavens; M Rigby; D J Sirinathsinghji; D C Dean; D G Melillo; A A Patchett; R Nargund; P R Griffin; J A DeMartino; S K Gupta; J M Schaeffer; R G Smith; L H Van der Ploeg Journal: Science Date: 1996-08-16 Impact factor: 47.728
Authors: Matthew Carmen; Debra Lynn Safer; Laura R Saslow; Tro Kalayjian; Ashley E Mason; Eric C Westman; Shebani Sethi Dalai Journal: J Eat Disord Date: 2020-01-29
Authors: Ruixin Zhu; Mikael Fogelholm; Thomas M Larsen; Sally D Poppitt; Marta P Silvestre; Pia S Vestentoft; Elli Jalo; Santiago Navas-Carretero; Maija Huttunen-Lenz; Moira A Taylor; Gareth Stratton; Nils Swindell; Niina E Kaartinen; Tony Lam; Teodora Handjieva-Darlenska; Svetoslav Handjiev; Wolfgang Schlicht; J Alfredo Martinez; Radhika V Seimon; Amanda Sainsbury; Ian A Macdonald; Margriet S Westerterp-Plantenga; Jennie Brand-Miller; Anne Raben Journal: Front Nutr Date: 2021-06-01
Authors: Faiza Kalam; Kelsey Gabel; Sofia Cienfuegos; Eric Wiseman; Mark Ezpeleta; Malik Steward; Vasiliki Pavlou; Krista A Varady Journal: Obes Sci Pract Date: 2019-09-13